Peganum harmala L. differentially modulates cytochrome P450 gene expression in human hepatoma HepG2 cells

Drug Metabolism Letters

Volumn 3, Issue 4, 2009, Pages 212-216

  El Gendy, Mohamed A M ^a   El Kadi, Ayman O S ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Cytochrome P450; HepG2 cells; Peganum harmala L.

Indexed keywords

CYTOCHROME P450; CYTOCHROME P450 1A2; CYTOCHROME P450 2B6; CYTOCHROME P450 2C19; CYTOCHROME P450 2D6; CYTOCHROME P450 2E1; CYTOCHROME P450 3A4; PEGANUM HARMALA EXTRACT;

ARTICLE; CELL STRAIN HEPG2; DRUG METABOLISM; GENE EXPRESSION; HERB DRUG INTERACTION; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; NONHUMAN; PEGANUM HARMALA; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; ZYGOPHYLLACEAE;

CYTOCHROME P-450 ENZYME SYSTEM; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION; HEP G2 CELLS; HUMANS; PEGANUM; PLANT EXTRACTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

PEGANUM HARMALA; ZYGOPHYLLACEAE;

EID: 74749109680     PISSN: 18723128     EISSN: None     Source Type: Journal    
DOI: 10.2174/187231209790218163     Document Type: Article

References (23)

1. Hu, Z.; Yang, X.; Ho, P. C.; Chan, S. Y.; Heng, P. W.; Chan, E.; Duan, W.; Koh, H. L.; Zhou, S. Herb-drug interactions: a literature review. Drugs, 2005, 65(9), 1239-1282.
2. Lamchouri, F.; Settaf, A.; Cherrah, Y.; Zemzami, M.; Lyoussi, B.; Zaid, A.; Atif, N.; Hassar, M. Antitumour principles from Peganum harmala seeds. Therapie, 1999, 54(6), 753-758.
3. Wang, Y.; Al-Gazzar, A.; Seibert, C.; Sharif, A.; Lane, C.; Griffiths, W. J. Proteomic analysis of cytochromes P450: a mass spectrometry approach. Biochem. Soc. Trans., 2006, 34(Pt 6), 1246-1251.
4. Tanaka, E. Clinically important pharmacokinetic drug-drug interactions: role of cytochrome P450 enzymes. J. Clin. Pharm. Ther., 1998, 23(6), 403-416.
5. Donato, M. T.; Lahoz, A.; Castell, J. V.; Gomez-Lechon, M. J. Cell lines: a tool for in vitro drug metabolism studies. Curr. Drug. Metab., 2008, 9(1), 1-11.
6. Usui, T.; Saitoh, Y.; Komada, F. Induction of CYP3As in HepG2 cells by several drugs. Association between induction of CYP3A4 and expression of glucocorticoid receptor. Biol Pharm. Bull., 2003, 26(4), 510-517.
7. Elizondo, G.; Medina-Diaz, I. M. Induction of CYP3A4 by 1alpha,25-dyhydroxyvitamin D3 in HepG2 cells. Life Sci., 2003, 73(2), 141-149.
8. Medina-Diaz, I. M.; Elizondo, G. Transcriptional induction of CYP3A4 by o,p'-DDT in HepG2 cells. Toxicol. Lett., 2005, 157(1), 41-47.
9. Li, L.; Stanton, J. D.; Tolson, A. H.; Luo, Y.; Wang, H. Bioactive terpenoids and flavonoids from Ginkgo biloba extract induce the expression of hepatic drug-metabolizing enzymes through pregnane X receptor, constitutive androstane receptor, and aryl hydrocarbon receptor-mediated pathways. Pharm. Res., 2009, 26(4), 872-882.
10. Mandlekar, S.; Hong, J. L.; Kong, A. N. Modulation of metabolic enzymes by dietary phytochemicals: a review of mechanisms underlying beneficial versus unfavorable effects. Curr Drug Metab., 2006, 7(6), 661-675.
11. Korashy, H. M.; El-Kadi, A. O. The role of aryl hydrocarbon receptor and the reactive oxygen species in the modulation of glutathione transferase by heavy metals in murine hepatoma cell lines. Chem. Biol. Interact., 2006, 162(3), 237-248.
12. Zordoky, B. N.; El-Kadi, A. O. Induction of several cytochrome P450 genes by doxorubicin in H9c2 cells. Vascul. Pharmacol., 2008, 49(4-6), 166-172.
13. Livak, K. J.; Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods, 2001, 25(4), 402-408.
14. Arayne, M. S.; Sultana, N.; Bibi, Z. Grape fruit juice-drug interactions. Pak. J. Pharm. Sci., 2005, 18(4), 45-57.
15. Di, Y. M.; Li, C. G.; Xue, C. C.; Zhou, S. F. Clinical drugs that interact with St. John's wort and implication in drug development. Curr. Pharm. Des., 2008, 14(17), 1723-1742.
16. Pelkonen, O.; Turpeinen, M.; Hakkola, J.; Honkakoski, P.; Hukkanen, J.; Raunio, H. Inhibition and induction of human cytochrome P450 enzymes: current status. Arch. Toxicol., 2008, 82(10), 667-715.
17. Hummerich, J.; Zohm, C.; Pfau, W. Modulation of cytochrome P450 1A1 by food-derived heterocyclic aromatic amines. Toxicology, 2004, 199(2-3), 231-240.
18. Wortham, M.; Czerwinski, M.; He, L.; Parkinson, A.; Wan, Y. J. Expression of constitutive androstane receptor, hepatic nuclear factor 4 alpha, and P450 oxidoreductase genes determines interindividual variability in basal expression and activity of a broad scope of xenobiotic metabolism genes in the human liver. Drug. Metab. Dispos., 2007, 35(9), 1700-1710.
19. Cerveny, L.; Svecova, L.; Anzenbacherova, E.; Vrzal, R.; Staud, F.; Dvorak, Z.; Ulrichova, J.; Anzenbacher, P.; Pavek, P. Valproic acid induces CYP3A4 and MDR1 gene expression by activation of constitutive androstane receptor and pregnane X receptor pathways. Drug Metab. Dispos., 2007, 35(7), 1032-1041.
20. Akiyama, T. E.; Gonzalez, F. J. Regulation of P450 genes by liverenriched transcription factors and nuclear receptors. Biochim Biophys Acta, 2003, 1619(3), 223-234.
21. Inoue, K.; Negishi, M. Nuclear receptor CAR requires early growth response 1 to activate the human cytochrome P450 2B6 gene. J. Biol. Chem., 2008, 283(16), 10425-10432.
22. Kohalmy, K.; Tamasi, V.; Kobori, L.; Sarvary, E.; Pascussi, J. M.; Porrogi, P.; Rozman, D.; Prough, R. A.; Meyer, U. A.; Monostory, K. Dehydroepiandrosterone induces human CYP2B6 through the constitutive androstane receptor. Drug Metab. Dispos., 2007, 35(9), 1495-1501.
23. Honkakoski, P.; Negishi, M. Regulation of cytochrome P450 (CYP) genes by nuclear receptors. Biochem. J., 2000, 347(Pt 2), 321-337.